Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Fabino Life Sciences IPO.
July 22, 2024 12:24:00 PM
Actuate Therapeutics was already keeping its planned IPO on the modest side, but the cancer-focused biotech has now lowered those expectations even further. | Actuate Therapeutics was already keeping ...
Published by : FierceBiotechJuly 10, 2024 10:28:00 AM
Stay Updated with Latest Share Market News, Share Market Live Updates, Sensex Today, Nifty Live, IPO News, BSE/NSE News, Mutual Funds and Commodity Market News Updates on Business Standard.
Published by : Business StandardJuly 19, 2024 12:26:00 PM
Artiva Biotherapeutics has upsized its IPO to $167 million as the allogeneic natural killer (NK) cell therapy prepares to list on the Nasdaq this morning. | The biotech has knocked its share price ...
Published by : FierceBiotechJuly 15, 2024 10:30:26 AM
Private equity major TPG Capital-backed Sai Life Sciences has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO). The company's ...
Published by : Republic World on MSNJuly 15, 2024 10:34:51 AM
Sai Life Sciences, backed by private equity giant TPG Capital, has filed preliminary papers with the Securities and Exchange Board of India (Sebi) to raise funds through an initial public offering ...
Published by : Republic Business on MSNThe IPO Shares of Fabino Life Sciences Limited IPO are proposed to list on Thursday, January 13, 2022 at BSE SME. The public issue of Fabino Life Sciences IPO was opened on Dec 31, 2021 and closed for subscription on Jan 5, 2022. Fabino Life Sciences IPO Listing Date and Information:
| Listing Date | Thursday, January 13, 2022 |
| BSE Script Code | 543444 |
| NSE Symbol | |
| Listing In | MT Group of Securities |
| ISIN | INE0DRT01018 |
| Issue Price | ₹36 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
The allotment status of Fabino Life Sciences Limited IPO is now available online. The public issue of Fabino Life Sciences IPO was open on Dec 31, 2021 and closed for subscription on Jan 5, 2022. The equity shares of the company to be list at BSE SME.
Fabino Life Sciences Limited is entering in the capital market with an IPO of 900,000 Equity Shares of Rs 10 aggregating up to Rs 3.24 Crore. The price for the issue has been set at Rs 36 Per Equity Share.
Fabino Life Sciences is engaged in the manufacturing, marketing, trading, and packing of pharmaceutical and other wellness-focused consumer products. The company's core business is the marketing of pharmaceutical formulation & products in the domestic market through their own distribution network and sales force under their brand name, getting ayurvedic formulations manufactured through loan licensing facilities, packing, labeling, etc. The company export wellness and FMCG products like coffee, malt powder, protein powder, hair shampoo marketed by them.
The issue opens on Dec 31, 2021 and closes for subscription on Jan 5, 2022. The equity shares of the company to be list at BSE SME.
The issue of Fabino Life Sciences Limited opens on Dec 31, 2021 and closes for subscription on Jan 5, 2022. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 36 Per Equity Share.
The Fabino Life Sciences IPO is proposed to open on December 31, 2021. The IPO application ends on January 5, 2022.
Retail investors can apply in the retail or non-institutional investor category from December 31, 2021 to January 5, 2022. The Fabino Life Sciences IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Fabino Life Sciences IPO will open for subscription on December 31, 2021. The public issue will close on January 5, 2022.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
